The systemic vasculitides are a group of diseases of unknown cause. The common pathological finding is a chronic, necrotising, inflammation of blood vessels that may be associated with granulomata. The clinical presentation is variable and depends on the site and size of vessels involved. The initial features can range from sinusitis or epistaxis to fulminating pulmonaryrenal failure. Usually there is constitutional disturbance with fever, malaise, and weight loss. There may also be concurrent infection which can exacerbate the underlying autoimmune process. Early and accurate diagnosis is essential for optimal treatment and is based on tissue biopsy and serological analysis.
Wegener's granulomatosis, microscopic polyarteritis, Henoch-Schonlein disease, polyarteritis nodosa, Churg-Straus disease and other primary vasculitic syndromes have traditionally been diagnosed on the basis of specific clinicopathological criteria. 1 However, this classification is inadequate since overlap does occur between the syndromes, and diagnostic clinical features may not be evident at the time of presentation. Alternatively, classification may be defined using a morphological approach according to vessel size (Table  1 ). Growing evidence shows that most forms of primary vasculitis are associated with the presence of circulating autoantibodies to neutrophil cytoplasmic antigens (AN CA) and their detection now forms the basis of a reliable diagnostic test. 4 ,9 AN CA are not only useful for diagnosis but are also valuable for monitoring therapy, since it has been found that these levels correlate with disease activity. 13 The value of these tests in the management of patients with systemic vasculitis is particularly relevant for intensive care, since it has been found that certain sUbtypes of ANCA are associated with severe multi system disease. 14, 15 This paper describes the presentation and course of seven patients with fulminant systemic vasculitis treated in our intensive care over a four-year period. 
CASE REPORTS Patient 1
A 65-year-old man presented with malaise, fever and green sputum from a left basal pneumonia. He rapidly developed a purpuric rash over his chest, toes and soles of his feet. There was evidence of a mononeuritis multiplex, with numbness and weakness of both his forearms. In addition, he had haematuria, became oliguric, and plasma concentrations of urea and creatinine increased to 30 mmolll and 680 {tmolll respectively. His haemoglobin was 8.7 g/dl, erythrocyte sedimentation rate 83 mm/hr and C-reactive protein 190 mg/1. A renal biopsy showed necrotising glomerulonephritis with vasculitis. Serology confirmed this vasculitis to be ANCA positive (28070; normal range < 16%) and anti-glomerular basement membrane (AGBM) negative. He suddenly became dyspnoeic and his mean arterial pressure decreased to 55 mmHg. Chest X-ray showed widespread basal shadowing consistent with alveolar haemorrhage. An indiumlabelled white cell scan was done to localise inflammation. It showed high uptake of radioisotope in both kidneys and also in the hilum of the left lung.
He was transferred to the intensive care unit where his trachea was intubated and ventilatory support started. A pulmonary artery catheter was inserted and his measured cardiac index (Cl) was 4.6 IImin/m2, pulmonary capillary wedge pressure (PCWP) 3 mmHg and systemic vascular resistance (SVR) 571 dyn.s/cm 5 • He was resuscitated with colloid and inotropic support started with noradrenaline. His D02I and V02I were then measured as 773 and 123 mI.min/m 2 respectively. Haemodiafiltration was commenced as he was in renal failure and the serum potassium was 6.7 mmollI. Pulmonary haemorrhage caused progressive opacification of his left lung field. He developed a right-sided tension pneumothorax that precipitated ventricular fibrillation. Bilateral chest drains were inserted and after a single DC shock he reverted to sinus rhythm. Gram-negative sepsis complicated his illness and further inotropic support with dobutamine was needed. Amiodarone was given for episodes of supraventricular tachycardia. His underlying vasculitis was treated with cyclophosphamide (2 mg/kg/day) and hydrocortisone (2 mg/kg/day). Plasmapheresis was commenced and IgG immunoglobulin (2 g/kg) was given intravenously. Disease activity responded to this therapy and ANCA titres decreased to normal concentration « 16070).
His course in the ICU remained stormy. A persistent pneumothorax associated with a bronchopleural fistula and pleural effusion made it difficult to wean him from respiratory support. He developed a right hemiparesis, gastrointestinal bleeding, a right panophthalmitis and further episodes of vasculitic rash and haemoptysis. On day 39 he died from a large fronto-parietal intracranial haemorrhage. Post-mortem examination revealed disseminated invasive aspergillosis affecting brain, lungs, thyroid and kidney. Involvement of the cerebral vasculature with aspergillosis was responsible for his intracranial haemorrhage (Figure la, b ). There was no evidence of active vasculitis.
Patient 2
A 27-year-old man presented with a three-day history of malaise, night sweats and nocturia, associated with haemoptysis and the appearance of a purpuric rash on his knees, shins and elbows. Over the previous three months he had complained of sinusitis, epistaxis, deafness, ophthalmitis and migratory arthralgia. Examination showed him to be dyspnoeic and unwell, with bilateral coarse inspiratory crepitations to midzone on auscultation. Chest X-ray showed bilateral airspace shadowing consistent with pulmonary haemorrhage (Figure 2a ). A renal biopsy for haematuria and deteriorating renal function showed acute proliferative necrotising glomerulonephritis. AN CA was positive (42%), AGBM negative and C-reactive protein 152 mg/I. Immunosuppressant therapy with cyclophosphamide and hydrocortisone was started. Intravenous IgG was administered and plasmapheresis commenced.
He became more dyspnoeic and hypoxic as his haemoptysis worsened. His haemoglobin decreased to 6.6 g/dl, and mean arterial pressure to 52 mmHg. He was transferred to the intensive care unit where his FIGURE 2a: Chest X-ray of patient 2 at presentation, with endotracheal tube and subclavian central venous line in situ. There is marked widespread bilateral airspace shadowing from pulmonary haemorrhage.
AnaeSlhesia and inlensive Care, Vo!. 22, No. 1, February, 1994 trachea was intubated and ventilatory support commenced. A pulmonary artery catheter was inserted and his measured Cl was 10 IImin/m2, PCWP 7 mmHg, and SVR 172 dyn.s/cm 5 • Resuscitation with colloid, blood transfusion and noradrenaline improved his haemodynamic state. D02I and V02I were 649 and 288 ml.min/m 2 . However, he became oliguric, urea and creatinine serum concentrations increasing to 29 mmolll and 418 vmolll respectively. Haemodiafiltration was started, blood cultures taken and ciprofloxacin given for antimicrobial cover.
Pulmonary gas exchange remained poor, an Fi02 > 0.8 with 10 cm PEEP was needed to maintain arterial oxygen tension above 8.8 kPa. Pulmonary bleeding persisted and, as the left lung airspace completely opacified, airway pressure increased and arterial saturation decreased to 85070. Inverse-ratio ventilation (2:1) improved oxygenation transiently. However, he developed surgical emphysema which extended over his face and chest. Chest X-ray ( Figure 2b ) showed bilateral pneumothoraces, the left under tension, together with pneumomediastinum and pneumopericardium. Despite bilateral chest drains, his surgical emphysema worsened and he continued to have periods of arterial desaturation. He remained hypotensive, with a persistently low SVR, despite noradrenaline. On the fifth day the left tension pneumothorax recurred and he had a cardiac arrest. Bilateral chest drains were reinserted but he became asystolic and did not respond to resuscitative efforts. 
Patient 3
A 56-year-old woman presented in acute respiratory failure after a two-week illness with anorexia, vomiting, back pain, cough with purulent sputum and widespread maculopapular rash on her hands and feet. Her -1naesthesia and Intensive Care, Vol. 22 , No. 1, February, 1994 trachea was immediately intubated and ventilatory support given. Tracheal aspiration was bloodstained and chest X-ray showed diffuse bilateral infiltrates, suggesting pulmonary haemorrhage. She was hypotensive and her haemoglobin concentration was 8.0 g/dl. Colloid, blood and dobutamine and dopamine were required for resuscitation. After this her cardiac index was 4.8 IImin/m2, SVR 720 dyn.s/cm 5 , MAP 93 mmHg, D021 751 ml.min/m 2 and V02I 203 ml.min/m 2 .
She was anuric, the serum concentrations of urea and creatinine were 94 mmolll and 1949 mmolll respectively and serum potassium was 8.2 mmolll. Haemodiafiltration was started and a renal biopsy showed crescentic glomerulonephritis. Biopsy of her skin lesions confirmed necrotising vasculitis, with immunofluorescence positive for IgG and C3. ANCA were detected (93070) and a diagnosis of Wegener's granulomatosis was made. Immunosuppressant therapy with cyclophosphamide and hydrocortisone was given, together with intravenous IgG administration and plasmapheresis. The circulating concentration of ANCA decreased in response to this ( Figure 3 ). Her course was complicated by continuing pulmonary haemorrhage with progressive opacification of both lung fields on chest X-ray, bronchospasm, pleural effusions and lobar consolidation. An inspired oxygen concentration of 0.8 (7 cm PEEP) was needed to maintain oxygenation. She developed Gram-negative septicaemia with Ps. aeruginosa, and noradrenaline was needed to support her labile arterial pressure for two weeks. On Day 25 she bled from a rectal ulcer which necessitated a ten-litre blood transfusion. The ulcer was confirmed angiographically and surgically repaired. AN CA concentration decreased as her condition began to improve. She was gradually weaned from respiratory support and needed only intermittent haemodialysis. She was discharged from the intensive care unit and eventually returned home. Six months later her serum creatinine was 220 mmolll and ANCA titre was negative.
Patient 4
This 61-year-old male presented with haemoptysis and increasing breathlessness. Chest X-ray showed widespread alveolar shadowing and bronchoscopy confirmed pulmonary haemorrhage. He became oliguric and serum creatinine increased to 351 mmolll. AGBM was negative and ANCA was positive. Renal biopsy showed normal glomerular architecture, with widespread deposits of IgG and IgM on direct immunofluorescence. Immunosuppression with cyclophosphamide and hydrocortisone was started. His pyrexia and leucocytosis were treated with ciprofloxacin.
However, he became increasingly dyspnoeic and mean arterial pressure decreased to 50 mmHg. Chest X-ray confirmed increased alveolar shadowing from pulmonary haemorrhage. He was immediately supported with synchronised intermittent mandatory ventilation. An inspired oxygen concentration of 0.7 with 8 cm PEEP maintained oxygenation. Hb was 9.1 g/dl and Cl was 4.5 lImin/m2, PCWP 15 mmHg and SVR 360 dyn.s/cm 5 . His arterial pressure improved with colloid, blood transfusion and noradrenaline. Once haemodynamically stable, plasmapheresis was commenced and he was given a daily 4 I exchange.
Over the next 48 hours his condition improved, with urine output returning to normal, and he was weaned from SIMV to CPAP and extubated 24 hours later. He remained in the intensive care unit for five days.
Patient 5
This previously well 25-year-old man presented with rigors, haemoptysis, dyspnoea and right pleuritic chest pain. One month before he had complained of otalgia, deafness and intermittent epistaxis. Chest X-ray showed right basal opacification and pleural effusion. This failed to resolve with antibiotic therapy and a subsequent transbronchial biopsy showed necrotising vasculitis with giant cells, consistent with Wegener's granulomatosis. The ANCA titre was positive (900/0). His renal function deteriorated, with serum urea and creatinine increasing to 35 mmolll and 400 {tmolll respectively. He developed pericarditis due to uraemia, and intermittent haemodialysis was commenced. A necrotising proliferative glomerulonephritis was found on renal biopsy. Immunosuppressant therapy and plasmapheresis were started.
He then developed acute pancreatitis and a large haemorrhagic pancreatic pseudocyst was confirmed by computerised tomography. Splenectomy and surgical drainage of the pseudocyst were performed. However, over the next two months he became cachectic and debilitated due to chronic pancreatic inflammation. These clinical relapses correlated with a rise in ANCA titre (Figure 4 ). Ps. aeruginosa was isolated from a pleural effusion and he became hypotensive, needing artificial ventilation and resuscitation with colloid, dobutamine and noradrenaline. Cl was measured as 7.2 lImin/m2, SVR 542 dyn.~!cm5, PCWP 20 mmHg, D021 630 ml.min/m2, and V021 130 ml.min/m 2 . He became thrombocytopaenic and developed a coagulopathy. His renal function required further support with haemodiafiltration. His condition remained poor and was further complicated by intra-abdominal bleeding, haematemesis and pulmonary haemorrhage. Angiography indicated bleeding from an eroded pancreatic vessel. This resulted in a massive right subphrenic haematoma, which caused inferior vena caval obstruction. He remained inotrope dependent and increasing inspiratory oxygen concentrations of over 0.8 (10 cm PEEP) were required for oxygenation. Despite these supportive measures, he died. 
Patient 6
This 61-year-old man presented with haemoptysis, transient arthralgia and anaemia. Recurrent haemoptysis had occurred over the previous eight months, but bronchoscopy had been unremarkable. His symptoms worsened and chest X-ray showed extensive bilateral mid-zone shadowing and the haemoglobin decreased to 8.5 g/dl. Over the next four days his pulmonary and renal function deteriorated rapidly. He became increasingly dyspnoeic and oliguric, with serum creatinine increasing to 674 {tmolll, and urea 57 mmolll. His ESR was 84 mm/hr, AN CA titre was positive (85%), and a renal biopsy showed crescentic glomerulonephritis. Immunosuppression with cyclophosphamide and methylprednisolone was given. He was transferred to the intensive care unit where he was given ventilatory support and started on haemodiafiltration. Oxygenation was maintained with an Fr02 of 0.60, and 5 cm PEEP. He was transfused and further treated with plasmapheresis and immunoglobulin. He remained haemodynamically stable. Over the next five days pulmonary haemorrhage subsided and his respiratory function improved. His trachea was then extubated and in the following week haemodiafiltration stopped. He was discharged from the intensive care unit, and eventually returned home.
Patient 7
This 75-year-old man presented with a two-month history of malaise, abdominal pain and increasing breathlessness. Two weeks before admission he developed cough, purulent sputum and haemoptysis. On admission he was oliguric and in acute renal failure. Serum urea was 49 mmolll, creatinine 1237 jtmolll and potassium 5.6 mmolll. His Hb was 10.7 gldl and white cell count 32.5 X 10- 9 11 . Serology was positive for IgG (72070) and IgM ANCA, but AGBM was negative. Intermittent haemodialysis was started. Over the next 24 hours he became more dyspnoeic as his haemoptysis worsened, and he was transferred to the intensive care unit. Arterial oxygen partial pressure was 4.9 kPa (Fr02 0.24). His Pa02 improved to 8.0 kPa with an Fr02 of 0.6 (PEEP 5 cm). Chest X-ray showed extensive bilateral alveolar shadowing consistent with pulmonary haemorrhage. He was immunosuppressed with cyclophosphamide and prednisolone, and plasmapheresis was started. Over the next five days his clinical state improved markedly, and this was associated with a decrease in serum AN CA titre ( Figure 5 ). His haemoptysis diminished, and gas exchange improved. After discharge from the intensive care unit, he required regular haemodialysis for a further six months.
DISCUSSION
Fulminant vasculitis presents a major challenge, not only because of multi-organ system failure, but also because of the increased risk of complications, especially sepsis, which may arise from immunosuppressive therapy. The clinical presentation is usually that of pulmonary-renal failure (Tables 2, 3 ), but occasionally cerebral or gastrointestinal involvement may require admission to the intensive care unit. The fulminating nature illustrated in these cases emphasises the need for early diagnosis followed by prompt and aggressive intervention. Autoantibodies to neutrophil cytoplasmic antigens were first described in patients with renal vasculitis, 10 and subsequently have been found in the serum of patients with vasculitic syndromes (Table 1) . They form a family related in that they react against components of the neutrophil cytoplasm giving rise to characteristic appearances on indirect immunofluorescence. Examination after they have been overlaid on immobilised normal human neutrophils shows two main patterns of antibody binding: a granular cytoplasmic appearance (C-ANCA) and a predominantly perinuclear pattern (P-ANCA). C-ANCA bind mainly to a 29kD proteinase termed PR3 and most P-ANCA sera bind to myeloperoxidase (MPO). Reactivity to the 29kD proteinase has been correlated with a clinical diagnosis of Wegener's granulomatosis and anti-myeloperoxidase antibodies with microscopic polyarteritis and renal limited vasculitis. 7,11.12 The pathological basis for fulminating vasculitis is unclear but auto immune mechanisms are thought to be central to this process. 16 Recent evidence has implicated neutrophil cytoplasm antibodies in the pathogenesis of vasculitis. They may participate in injury by their direct effect on neutrophil activation, cells which are involved in the acute phase of inflammation. In vitro studies have shown these antibodies to cause neutrophils to degranulate, with release of toxic oxygen radicals.17 Furthermore, endothelial cells appear to be directly damaged by this process, an effect which is cytokine dependent. 18 Infection may also act as a trigger by amplifying this effect locally, again through the release of cytokines. Pulmonary haemorrhage is a common feature, occurring in 42070 of patients with Wegener's granulomatosis and 29070 with microscopic polyarteritis. 19, 20 In addition, nodular infiltrates, cavitation, pleural effusion, lobar collapse and bronchopleural fistula have all been reported. The widespread inflammation and necrosis of pulmonary capillaries ultimately leads to massive alveolar haemorrhage. Impairment of systemic oxygen delivery arises from decreased alveolar gas exchange and resultant anaemia from blood loss. Massive alveolar haemorrhage is associated with a high mortality, 2 1 and immediate priorities are therefore fluid resuscitation, with haemodynamic and respiratory support. Continuous positive pressure ventilation must be carefully monitored and an appropriate inspiratory waveform with pressure limitation chosen. The development of tension pneumothoraces in two of these seven patients occurred despite airway pressure monitoring. It suggests that the underlying disruption of lung parynchymal tissue was due to the vasculitic process. The reduced pulmonary compliance and functional residual capacity, increased shunt fraction and resultant hypoxaemia contributed to the need for a high inspired oxygen concentration. Similarly, the development of bronchopleural fistulae, surgical emphysema and pneumomediastinum all contribute to morbidity and the need for prolonged respiratory support.
The kidney is a particularly susceptible organ in systemic vasculitis. The characteristic renal lesion is a focal necrotising glomerulonephritis, with focal proliferation in milder disease. In rapidly progressive glomerulonephritis, the development of cellular crescents around the glomeruli results in compression of the glomerular tufts. Deterioration of renal function occurs over days to weeks, and may necessitate some form of renal replacement therapy. Although ANCA are considered to play a role in the pathogenesis of vasculitis, neither in the lung nor in the kidney is there evidence of deposition of immune reactants.
Gastrointestinal involvement may manifest as diarrhoea, bowel haemorrhage or perforation. Angiography and histological analysis of mucosal biopsy or resected tissue may be necessary to confirm vasculitic involvement. Steroid therapy itself can cause upper gastrointestinal ulceration with profuse bleeding requiring transfusion. Vasculitic involvement of the pancreatic vessels can lead to recurrent pancreatitis, and such involvement has recently been described in a patient with Wegener's granulomatosis. 22 This patient had similar features to patient 5 where recurrent abdominal pain and an increase in the plasma concentration of amylase occurred whenever there was a relapse in the vasculitic illness.
Neurological involvement is well recognised,23 and Anaesthesia and Intensive Care, Vol, 22, No, 1, February, 1994 includes encephalopathy, cranial nerve abnormalities, seizures, and intracranial haemorrhage. Occlusion of cerebral arteries by necrotising lesions and thrombosis may lead to cerebral infarction,24 while spontaneous subarachnoid haemorrhage has been reported in patients who have had normal cerebral angiography. 25 The intracranial haemorrhage that resulted from cerebral aspergillosis in patient 1 illustrates one of the sequelae of secondary infection in these patients. Peripheral neuropathies arise from vasculitis of the vasa vasorum and commonly present with features of mononeuritis multiplex. Such involvement emphasises the need for continuous neurological monitoring in these critically ill patients. Cardiac involvement may also occur in Wegener's granulomatosis and can manifest as myocarditis, coronary arteritis, valvulitis and endocarditis, conduction abnormalities and pericarditis. Acute pericardial inflammation may lead to life-threatening tamponade. 26 Ocular involvement may not only be an initial presenting feature but may also occur when systemic disease activity increases. Conjunctivitis, uveitis and retinal artery occlusion have all been described 27 and can result in blindness.
The prognosis of a fulminating vasculitic illness is poor. Before the advent of immunosuppression, Wegener's granulomatosis had a mean survival of five months and outcome was known to be worse in the presence of renal failure. Prognosis has improved with established regimens using steroids and cytotoxic agents. 23 ,28 Current therapy involves the use of highdose immunosuppression to induce a remission, followed later by a lower dosage to prevent relapse. However, therapy is limited by the complications of neutropenia, toxicity and partial response. Cyclophosphamide is the cytotoxic agent of choice, which inhibits both T -and B-lymphocytes, as well as modifying neutrophil function. The usual dosage of 1-2 mg/kg/day may be increased if required, is usually increased until there is a clinical response or leucopenia occurs. Myelosuppression is frequent but reversible. Corticosteroids are not only anti-inflammatory but may also provide protection against the myelosuppressive effects of cyclophosphamide. 23 The aim of therapy is to suppress disease activity without causing the cumulative adverse effects of neutropenia or haemorrhagic cystitis. Neutropenia, however, is used in some centres as an index of response to therapy. Azathioprine is a suitable alternative to cyclophosphamide in this situation. Our practice is to temporarily withdraw cytotoxic agents when the total cell count is less than 3.0 x 10-9 /1. However, there still exists a significant risk of infection with such regimens. 29 ,30 Diagnosis must therefore be accurate since immunosuppression in patients without vasculitis can result in serious morbidity. Current debate surrounds the use of additional therapy in systemic vasculitis. Plasma exchange has been used successfully in vasculitic patients who are dialysis dependent at presentation (patients 3 and 5).31 Also the method of plasmapheresis 32 will determine the efficiency of antibody removal, particularly IgM removal. If plasma filtration is used, and not total volume exchange, then the characteristics of the plasma filter will determine the efficiency of IgM removal. In comparison, cytocentrifugation is a more efficient mode of IgM removal. 15 In patient 7, this mode was used initially and resulted in the initial sharp fall in IgM ANCA ( Figure 5 ). When plasma filtration was subsequently used, the decline in IgM ANCA was less, matching the patient's slow recovery. The mode of action of plasma exchange may involve removal of specific autoantibodies such as IgM, and inflammatory mediators such as cytokines and complement which are confined to the intravascular compartment. There may also be effects on immune cellular responses. The complications of plasma exchange include infection from vascular access, hypotension, reaction to blood products, disruption of coagulation, hypogammaglobulinaemia and electrolyte disturbances.
Pooled intravenous immunoglobulin has been used successfully in AN CA positive patients with systemic vasculitis. 33 Reduction in disease activity is associated with decreases in both ANCA and CRP. The mechanism of action is not known but may be related to inhibition of autoantibody synthesis, effects on T-and B-cells, inhibition of complement and reduction in cytokine secretion. Other therapeutic approaches include antibiotic therapy with trimethoprim/sulfamethoxazole, 34 monoclonal antibody,35 cyclosporin A 36 and immunoabsorption techniques 37 as an alternative to plasma exchange.
The major complication of infection is particularly important in critically ill patients. Nosocomial infection is an ever-present risk in patients needing ventilatory support and invasive monitoring. 38 . 39 The diagnosis of sepsis in these patients may be difficult because of immunosuppression and nosocomial factors. However, concurrent infection at the time of presentation may not only be involved in the pathogenesis of the vasculitic illness but also in the later development of a septic state. Viral infection and bronchial sepsis have been postulated to influence the development and course of a vasculitic disease. Despite an initial response to therapy, the development of sepsis in these patients can precipitate a relapse of the underlying vasculitic illness, and this may be reflected in an increase in ANCA titre.
The important aspects of intensive care management include early diagnosis, appropriate and aggressive treatment regimens, the support of multi-organ failure and accompanying complications. Since vascular damage arises from an intravascular process, treatment should be aimed at removal of circulating antibodies with plasmapheresis. This is particularly important in patients with IgM ANCA associated pulmonary disease since outcome is poorer if this therapy is not used. 15 Identification of IgM ANCA autoantibodies involves specialised assay techniques, and laboratories should be specifically asked to utilise these. Such monitoring of disease activity with AN CA enables immunosuppressant therapy to be titrated carefully against adverse side-effects.
